Definitive Contract 75D30123C17693

Award Date 9/29/23
Potential Completion Date 9/28/25
Potential Value $2.1M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Harvard Pilgrim Health Care Inc. The $394,808 Firm Fixed Price contract is a Delivery Order under the CDC's Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) program. It does not have a set-aside designation. The contract is for the SHEPHERD-SAFETY AND HEALTHCARE EPIDEMIOLOGY PREVENTION RESEARCH DEVELOPMENT PROGRAM, which provides research and data analytics services to...
This federal contract award, valued at $3,708,202.00, was issued by the Centers for Disease Control and Prevention (CDC) to Harvard Pilgrim Health Care Inc.'s Office of Sponsored Programs Division, a non-profit healthcare organization. The contract is a Delivery Order under the CDC's Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) multiple-award indefinite delivery/indefinite quantity (IDIQ) contract vehicle, which supports the agency's efforts in areas such as...
This is a federal contract award to Harvard Pilgrim Health Care Inc., a non-profit healthcare organization, by the Centers for Disease Control and Prevention (CDC). The contract is for the SHEPHERD (Safety and Healthcare Epidemiology Prevention Research Development) program, a $4,451,893.31 firm fixed-price delivery order contract. The contract is not set aside and is part of a larger $99 million indefinite delivery/indefinite quantity (IDIQ) contract with the CDC to support epidemiological...
This is a $5,004,841.64 delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Harvard Pilgrim Health Care Inc. The contract is part of the larger Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) indefinite delivery/indefinite quantity (IDIQ) vehicle, which supports the CDC's public health research and data analytics initiatives. This specific delivery order is for "DOMAIN 1-A014 MODELING & DEVELOPMENT"...
This is a Delivery Order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Harvard Pilgrim Health Care Inc., a non-profit healthcare organization, for "Other Functions" under the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract, which has a potential value of $599,843.18, is a Firm Fixed Price vehicle with a completion date of...
This definitive contract for $854,292 was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Harvard Pilgrim Health Care Inc. to support surveillance for non-ventilator hospital-acquired pneumonia using structured electronic clinical data. The prime contractor will deliver services aligned with the goals of the Centers for Disease Control and Prevention's FY 2019 Broad Agency Announcement, which sought proposals to advance public health...
This is a $4,039,999.68 firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Harvard Pilgrim Health Care Inc. to provide a "Rapid Safety Surveillance Capability." The work supports the FDA's Sentinel Initiative, which monitors the post-market safety of medical products through electronic healthcare databases. As a non-profit organization, Harvard Pilgrim leverages its expertise in health data analytics, epidemiology, and program management to maintain...
This $565,000.00 firm fixed-price delivery order contract was awarded by the Department of Health and Human Services Food and Drug Administration to Harvard Pilgrim Health Care Inc., a non-profit health care organization. The contract is for OCET/SENTINEL ACTIVITIES, which likely refers to post-market safety monitoring of medical products and enhancing vaccine safety surveillance, based on Harvard Pilgrim's experience supporting the Food and Drug Administration's Sentinel Initiative and the...
This is a $546,714.33 cost-plus-fixed-fee delivery order contract awarded by the Food and Drug Administration (FDA) to Harvard Pilgrim Health Care Inc.'s Office of Sponsored Programs Division, a non-profit healthcare research organization. The contract supports research on genetic risk factors for idiopathic thrombocytopenic purpura following measles, mumps, and rubella vaccination in children. The contract is not set aside and is part of Harvard Pilgrim's extensive portfolio of federal...
This is a $8,614,570.87 delivery order contract awarded by the Food and Drug Administration (FDA) to Harvard Pilgrim Health Care Inc., a non-profit healthcare organization. The contract supports the FDA's Sentinel System for post-market medical product safety surveillance, including developing and maintaining the Sentinel Innovation Center and conducting comprehensive data analytics projects. The contract is not set-aside. Harvard Pilgrim Health Care Inc. has established itself as a critical...

This is a $2,090,402.00 firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to Harvard Pilgrim Health Care Inc. for the "Development and Application of a National Pediatric Sepsis Event Surveillance Definition." The contract does not have a set-aside designation.

Harvard Pilgrim Health Care Inc., a non-profit healthcare organization, will provide research and data analytics services to support the CDC's efforts in public health surveillance and vaccine safety monitoring. This includes leveraging Harvard Pilgrim's expertise in healthcare data, epidemiology, and clinical research to develop and apply a national definition for pediatric sepsis events.

The contract is part of Harvard Pilgrim's portfolio of federal contracts and grants, which demonstrate its capabilities in conducting innovative public health and healthcare research. Harvard Pilgrim holds several indefinite delivery/indefinite quantity (IDIQ) contracts with the CDC and Food and Drug Administration (FDA) to provide ongoing data analytics, pharmacoepidemiology, and public health research services to these key federal health agencies.

Generated 7/17/24, 9:15 AM